Ocular Therapeutix, Inc. (OCUL)
6.28
-0.59
(-8.59%)
USD |
NASDAQ |
Oct 19, 16:00
6.28
0.00 (0.00%)
After-Hours: 16:13
Ocular Therapeutix Cash from Operations (Annual) : -204.88M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -204.88M |
| December 31, 2024 | -134.68M |
| December 31, 2023 | -70.23M |
| December 31, 2022 | -59.60M |
| December 31, 2021 | -65.55M |
| December 31, 2020 | -53.55M |
| December 31, 2019 | -77.58M |
| Date | Value |
|---|---|
| December 31, 2018 | -49.23M |
| December 31, 2017 | -50.47M |
| December 31, 2016 | -34.00M |
| December 31, 2015 | -33.74M |
| December 31, 2014 | -20.50M |
| December 31, 2013 | -12.64M |
| December 31, 2012 | -12.58M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| EyePoint, Inc. | -240.11M |
| ANI Pharmaceuticals, Inc. | 185.22M |
| Eli Lilly & Co. | 16.81B |
| Corcept Therapeutics, Inc. | 142.00M |
| Veru, Inc. | -30.04M |